Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-23

Clinical Trial Update: Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rosuvastatin/ezetimibe versus rosuvastatin in Korean patients with type 2 diabetes mellitus and hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)
  • Rosuvastatin/Ezetimibe (rosuvastatin; ezetimibe)

Snippet

Sponsor: Yuhan Corporation | Conditions: Type 2 Diabetes Mellitus, Hypercholesterolemia | Phase 4 | Status: COMPLETED